Stockbroking | Wealth Management | Corporate Advice

x

Resizing text on the web

To increase or decrease the magnification of a web page, press Ctrl and '+' (plus) to zoom in or Ctrl and '-' (minus) to zoom out. To return the page to its original size, press Ctrl + 0.

You can also scroll the mouse wheel up and down while holding Ctrl to increase/decrease zoom level.

John Holaday, QRxPharma

Pain drug developer QRxPharma is approaching a key inflection point. With clinical trials complete and the regulator poised to make a decision on their pain drug MoxDuo in six months' time, there is potential for substantial capital gain.

It is not without risk, however a positive decision will see the share well through our A$1.79 price target.

The firm's Managing Director and CEO, Dr John Holaday, spoke to Morgans Senior Analyst Scott Power about the next steps involved in gaining approval for MoxDuo.

More information

Clients can login to view further research and analysis on QRxPharma.

Find an Office